NCT05259241 - ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI) | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

January 1, 2023

Conditions

Transcatheter Aortic Valve ReplacementPercutaneous Coronary Intervention

Interventions

DIAGNOSTIC_TEST

activated partial thrombin time

This study aims to find which the point-of-care test (ACT or APTT) has the best correlation with the coagulation status during transcatheter cardiac interventions (either TAVR or PCI)

Trial Locations (1)

3015GD

RECRUITING

Erasmus University Medical Center, Rotterdam